Here is What Hedge Funds Think About Abeona Therapeutics Inc (ABEO)

Consequently, key money managers have been driving this bullishness. DAFNA Capital Management, managed by Nathan Fischel, initiated the largest position in Abeona Therapeutics Inc (NASDAQ:ABEO). DAFNA Capital Management had $0.7 million invested in the company at the end of the quarter. Chuck Royce’s Royce & Associates also made a $0.2 million investment in the stock during the quarter. The only other fund with a new position in the stock is Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.

Let’s go over hedge fund activity in other stocks similar to Abeona Therapeutics Inc (NASDAQ:ABEO). We will take a look at Fenix Parts Inc (NASDAQ:FENX), JMP Group Inc. (NYSE:JMP), and Energy Fuels Inc Ordinary Shares (Canada) (NYSEMKT:UUUU). This group of stocks’ market valuations match Abeona Therapeutics Inc (NASDAQ:ABEO)’s market valuation.

As you can see, these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $17 million. That figure was $24 million in Abeona Therapeutics Inc (NASDAQ:ABEO)’s case. Fenix Parts Inc (NASDAQ:FENX) is the most popular stock in this table. On the other hand, JMP Group Inc. (NYSE:JMP) is the least popular one with only 4 bullish hedge fund positions. Compared to these stocks Abeona Therapeutics Inc (NASDAQ:ABEO) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.